Zoetis Raises Annual Forecast Amid Strong Demand for Pet Products

Zoetis Inc., a leader in animal healthcare, has recently raised its annual revenue and profit forecasts for 2025. This boost is largely driven by a surge in demand for pet medicines and vaccines. In the second quarter of this year, Zoetis’s companion animal segment reported an impressive 8% revenue increase. Products such as Simparica Trio and Librela have been key contributors to this growth, reflecting broader trends in the pet healthcare market.